Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxygen nanobubbles (ONBs) are sub-micron gas-filled cavities, typically less than 200 nm in diameter, that encapsulate high concentrations of oxygen within a stabilizing shell composed of lipids, polymers (such as PLGA), or surfactants. These nanostructures are designed to enhance oxygen delivery to tissues, bypassing or supplementing traditional pulmonary gas exchange. In clinical development, ONBs are being investigated for their ability to improve exercise tolerance in patients with pulmonary fibrosis and to enhance the efficacy of cancer therapies by mitigating tumor hypoxia. Preclinical studies also suggest potential applications in treating ischemic stroke, ocular diseases (like diabetic retinopathy), and inflammatory conditions such as colitis. Beyond medicine, oxygen nanobubbles are utilized in environmental engineering for water remediation and in agriculture to promote soil health and plant growth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxygen nanobubbles.